Acadian Asset Management
MIST icon

Acadian Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Acadian Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Sell
20,468
-155,732
-88% -$273K ﹤0.01% 1934
2025
Q4 		$353K Buy
+176,200
New +$380K ﹤0.01% 1406
2022
Q3 		– Sell
-13,717
Closed -$84K – 1778
2022
Q2 		$84K Sell
13,717
-5,553
-29% -$34.1K ﹤0.01% 1392
2022
Q1 		$122K Buy
19,270
+6,889
+56% +$43.1K ﹤0.01% 1322
2021
Q4 		$79K Buy
12,381
+4,785
+63% +$28.7K ﹤0.01% 1418
2021
Q3 		$42K Sell
7,596
-4,473
-37% -$25.2K ﹤0.01% 1576
2021
Q2 		$67K Buy
+12,069
New +$68.5K ﹤0.01% 1747

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Acadian Asset Management's MIST Position: Q1 2026 in Review

Acadian Asset Management reduced its Milestone Pharmaceuticals (MIST) stake by 88% in Q1 2026, selling an estimated $273K and leaving 20,468 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Acadian Asset Management first reported a position in MIST in Q2 2021 and has held it in 7 quarters since. The position peaked at $353K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Acadian Asset Management held 20,468 shares of Milestone Pharmaceuticals worth $24K as of Q1 2026.
  • Acadian Asset Management sold 155,732 Milestone Pharmaceuticals shares in Q1 2026, an estimated $273K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1934 holding.
  • Acadian Asset Management first reported a position in Milestone Pharmaceuticals in Q2 2021 and has held it in 7 quarters since.
  • Acadian Asset Management's Milestone Pharmaceuticals position peaked at $353K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.